2-Deoxy-D-glucose impedes T cell-induced apoptosis of keratinocytes in oral lichen planus

J Cell Mol Med. 2021 Nov;25(21):10257-10267. doi: 10.1111/jcmm.16964. Epub 2021 Oct 21.

Abstract

Oral lichen planus (OLP) is a T cell-mediated immunoinflammatory disease. Glycolysis plays an essential role in T-cell immune responses. Blocking glycolytic pathway in activated T cells represents a therapeutic strategy for restraint of immunologic process in autoimmune disorders. 2-Deoxy-D-glucose (2-DG) has been widely used to probe into glycolysis in immune cells. This study was aimed to explore the role of glycolysis inhibition by 2-DG on regulating immune responses of OLP-derived T cells. We observed that lactic dehydrogenase A (LDHA) expression was elevated in OLP lesions and local T cells. 2-DG inhibited the expression of LDHA, p-mTOR, Hif1α and PLD2 in T cells; meanwhile, it decreased proliferation and increased apoptosis of T cells. T cells treated by 2-DG showed lower LDHA expression and elevated apoptosis, resulting in a reduced apoptotic population of keratinocytes that were co-cultured with them, which was related to the decreased levels of IFN-γ in co-culture system. Rapamycin enhanced the effects of 2-DG on immune responses between T cells and keratinocytes. Thus, these findings indicated that OLP-derived T cells might be highly dependent upon high glycolysis for proliferation, and 2-DG treatment combined with rapamycin might be an option to alleviate T-cell responses, contributing to reducing apoptosis of keratinocytes.

Keywords: 2-deoxy-D-glucose; T cell; apoptosis; glycolysis; interferon-γ; keratinocyte; mammalian target of rapamycin; oral lichen planus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Proliferation / drug effects
  • Coculture Techniques
  • Deoxyglucose / pharmacology*
  • Glucose / metabolism
  • Glycolysis
  • Humans
  • Interferon-gamma / metabolism
  • Keratinocytes / drug effects*
  • Keratinocytes / metabolism*
  • Keratinocytes / pathology
  • Lichen Planus, Oral / etiology*
  • Lichen Planus, Oral / metabolism*
  • Lichen Planus, Oral / pathology
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology
  • Signal Transduction / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Interferon-gamma
  • Deoxyglucose
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Glucose